|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 133.05 USD | -1.40% |
|
-2.38% | +8.40% |
| 05-13 | US FDA approves BeOne's drug for a type of blood cancer | RE |
| 05-12 | Gilead Sciences, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 02:20 PM |
Official Publications
| 05-06 | SEC Filing 8K | CO |
| 05-06 | SEC Filing 10Q-1 | CO |
| 05-06 | Slide show Q1 | CO |
| 05-06 | 1st quarter results | CO |
| 02-23 | SEC Filing 10K | CO |
| 02-09 | SEC Filing 8K | CO |
| 02-09 | Slide show results | CO |
| 02-09 | Annual results | CO |
| 02-04 | SEC Filing 13G | CO |
| 11-06 | SEC Filing 10Q-3 | CO |
| 29/10/25 | SEC Filing 8K | CO |
| 29/10/25 | Slide show Q3 | CO |
| 29/10/25 | 3rd quarter results | CO |
| 06/08/25 | SEC Filing 8K | CO |
| 06/08/25 | SEC Filing 10Q-2 | CO |
| 06/08/25 | Slide show half-year results | CO |
| 06/08/25 | 1st-half-year results | CO |
| 06/05/25 | Shareholders meeting voting results | CO |
| 06/05/25 | SEC Filing 10Q-1 | CO |
| 23/04/25 | SEC Filing 8K | CO |
| 23/04/25 | Slide show Q1 | CO |
| 23/04/25 | 1st quarter results | CO |
| 26/03/25 | Proxy Statments | CO |
| 27/02/25 | SEC Filing 10K | CO |
| 10/02/25 | SEC Filing 8K | CO |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















